The fragile X syndrome: exploring its molecular basis and seeking a treatment

Area of Science:

• Neurogenetics
• Molecular Biology
• Developmental Disorders

Background:

• Fragile X syndrome (FXS) is a leading inherited cause of intellectual disability.
• It stems from the absence of the FMR1 gene's protein product, FMRP.
• FMRP is crucial for neuronal mRNA regulation, including translation, trafficking, and targeting.

Purpose of the Study:

• To review recent findings on FMRP function.
• To elucidate how FMRP absence leads to FXS clinical features.
• To explore potential therapeutic interventions for FXS.

Main Methods:

• Literature review of functional studies on FMRP.
• Analysis of protein-protein and protein-RNA interactions involving FMRP.
• Investigation of cellular pathways linked to FMRP, such as RhoGTPase and RNA interference.

Main Results:

• FMRP interacts with numerous protein partners and mRNA targets.
• FMRP's functions are linked to cytoskeleton remodeling and mRNA processing.
• Understanding these interactions provides insights into FXS pathogenesis.

Conclusions:

• The absence of FMRP disrupts critical neuronal processes, leading to FXS phenotypes.
• Further research into FMRP's molecular functions is key to developing effective treatments.
• Targeting FMRP pathways offers potential therapeutic avenues for FXS.